Gene Garrard Olinger Jr.

Gene Garrard Olinger Jr.

Boston University

H-index: 56

North America-United States

About Gene Garrard Olinger Jr.

Gene Garrard Olinger Jr., With an exceptional h-index of 56 and a recent h-index of 39 (since 2020), a distinguished researcher at Boston University, specializes in the field of Virology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Methods of modeling in vivo efficacy of drug combinations for treatment of viral infections

Retrospective on molecular assay design for detecting pan-orthopox viruses and prospective on mpox laboratory preparedness and readiness

Climate change and infectious disease: A prologue on multidisciplinary cooperation and predictive analytics

Leveraging Geospatial Information to address Space Epidemiology through Multi $\unicode {x2013} $ omics $\unicode {x2013} $ Report of an Interdisciplinary Workshop

Analytical Optimization of GeneXpert Ultra for Detection of Tuberculosis in CSF Samples

Biotechnology and Biodefense Enterprise: An Industry Perspective on Defence Acquisition

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

Global health security threats and related risks in Latin America

Gene Garrard Olinger Jr. Information

University

Position

Adjunct Professor Medicine

Citations(all)

10996

Citations(since 2020)

5244

Cited By

8376

hIndex(all)

56

hIndex(since 2020)

39

i10Index(all)

95

i10Index(since 2020)

77

Email

University Profile Page

Google Scholar

Gene Garrard Olinger Jr. Skills & Research Interests

Virology

Top articles of Gene Garrard Olinger Jr.

Title

Journal

Author(s)

Publication Date

Methods of modeling in vivo efficacy of drug combinations for treatment of viral infections

2024/4/18

Retrospective on molecular assay design for detecting pan-orthopox viruses and prospective on mpox laboratory preparedness and readiness

Frontiers in Tropical Diseases

Kenneth B Yeh

Michael D Powers

Ami Patel

Falgunee Parekh

Ashley S Tseng

...

2023/7/26

Climate change and infectious disease: A prologue on multidisciplinary cooperation and predictive analytics

Frontiers in public health

Kenneth B Yeh

Falgunee K Parekh

Illich Mombo

Joseph Leimer

Roger Hewson

...

2023/1/20

Leveraging Geospatial Information to address Space Epidemiology through Multi $\unicode {x2013} $ omics $\unicode {x2013} $ Report of an Interdisciplinary Workshop

arXiv preprint arXiv:2308.07339

Annette L Sobel

Kenneth Yeh

Elaine Bradford

Colin Price

Joseph Russell

...

2023/8/12

Analytical Optimization of GeneXpert Ultra for Detection of Tuberculosis in CSF Samples

Journal of Tuberculosis Research

Victoria L Campodónico

Derek T Armstrong

Gene Olinger

Erin A Merritt

Ryan Howard

...

2023/7/28

Biotechnology and Biodefense Enterprise: An Industry Perspective on Defence Acquisition

Global Security: Health, Science and Policy

Kenneth B Yeh

Eric Du

Gene Olinger

Donna Boston

2022/12/31

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

Drug Repurposing for COVID-19 Therapy

Filippo Drago

Charles Daniel Murin

Gene Garrard Olinger

Paul Harris

2021/10/14

Global health security threats and related risks in Latin America

Global Security: Health, Science and Policy

Kenneth B Yeh

Falgunee K Parekh

Brooke Borgert

Gene G Olinger

Jeanne M Fair

2021/1/1

Significance of high-containment biological laboratories performing work during the COVID-19 pandemic: Biosafety level-3 and-4 labs

Frontiers in bioengineering and biotechnology

Kenneth B Yeh

Kairat Tabynov

Falgunee K Parekh

Illich Mombo

Kyle Parker

...

2021/8/13

COVID-19 vaccines: global challenges and prospects forum recommendations

Mohamed Boudjelal

Faisal Almajed

Ahmed M Salman

Naif K Alharbi

Margaretta Colangelo

...

2021/4/1

First movers in molecular detection: case comparison on harnessing research and development, industry, and entrepreneurship

Frontiers in Medicine

Kenneth B Yeh

Matt Scullion

Julia M Michelotti

Gene Olinger

2021/3/25

Drug combinations as a first line of defense against coronaviruses and other emerging viruses

Judith M White

Joshua T Schiffer

Rachel A Bender Ignacio

Shuang Xu

Denis Kainov

...

2021/12/21

Inhibition of arenaviruses by combinations of orally available approved drugs

Antimicrobial agents and chemotherapy

Shawn Herring

Jessica M Oda

Jessica Wagoner

Delaney Kirchmeier

Aidan O’Connor

...

2021/3/18

Sars-cov-2 supply shortages and tuberculosis diagnostics: Current issues requiring immediate solutions

Journal of clinical microbiology

Derek T Armstrong

Erin A Tacheny

Gene Olinger

Ryan Howard

M Megan Lemmon

...

2021/11/18

Formulation, stability, pharmacokinetic, and modeling studies for tests of synergistic combinations of orally available approved drugs against Ebola virus in vivo

Microorganisms

Courtney L Finch

Julie Dyall

Shuang Xu

Elizabeth A Nelson

Elena Postnikova

...

2021/3/10

MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses

Science

Anna Bruchez

Ky Sha

Joshua Johnson

Li Chen

Caroline Stefani

...

2020/10/9

Project IDentif. AI: harnessing artificial intelligence to rapidly optimize combination therapy development for infectious disease intervention

Advanced therapeutics

Aynur Abdulla

Boqian Wang

Feng Qian

Theodore Kee

Agata Blasiak

...

2020/7

Infectious disease risks and vulnerabilities in the aftermath of an environmental disaster in Minas Gerais, Brazil

Vector-Borne and Zoonotic Diseases

Falgunee K Parekh

Kenneth B Yeh

Gene Olinger

Flavia Andrade Ribeiro

2020/5/1

See List of Professors in Gene Garrard Olinger Jr. University(Boston University)